Ascelia Pharma (Sweden) Buy Hold or Sell Recommendation
| ACE Stock | SEK 2.90 0.11 3.65% |
Assuming the 90 days trading horizon and complete risk avoidance on your part, our recommendation regarding Ascelia Pharma AB is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Ascelia Pharma AB given historical horizon and risk tolerance towards Ascelia Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Ascelia Pharma AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Ascelia Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Ascelia and provide practical buy, sell, or hold advice based on investors' constraints. Ascelia Pharma AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Ascelia |
Execute Ascelia Pharma Buy or Sell Advice
The Ascelia recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ascelia Pharma AB. Macroaxis does not own or have any residual interests in Ascelia Pharma AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ascelia Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Ascelia Pharma Trading Alerts and Improvement Suggestions
| Ascelia Pharma AB is way too risky over 90 days horizon | |
| Ascelia Pharma AB appears to be risky and price may revert if volatility continues | |
| Ascelia Pharma AB has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (125.9 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ascelia Pharma AB has accumulated about 219.15 M in cash with (116.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.69, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 23.0% of the company shares are held by company insiders |
Ascelia Pharma Returns Distribution Density
The distribution of Ascelia Pharma's historical returns is an attempt to chart the uncertainty of Ascelia Pharma's future price movements. The chart of the probability distribution of Ascelia Pharma daily returns describes the distribution of returns around its average expected value. We use Ascelia Pharma AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ascelia Pharma returns is essential to provide solid investment advice for Ascelia Pharma.
| Mean Return | 0.56 | Value At Risk | -3.98 | Potential Upside | 12.92 | Standard Deviation | 5.39 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ascelia Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Ascelia Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ascelia Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ascelia Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ascelia stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.45 | |
β | Beta against Dow Jones | 0.74 | |
σ | Overall volatility | 5.39 | |
Ir | Information ratio | 0.08 |
Ascelia Pharma Volatility Alert
Ascelia Pharma AB shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Ascelia Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Ascelia Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Ascelia Pharma Fundamentals Vs Peers
Comparing Ascelia Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ascelia Pharma's direct or indirect competition across all of the common fundamentals between Ascelia Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ascelia Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Ascelia Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Ascelia Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Ascelia Pharma to competition |
| Fundamentals | Ascelia Pharma | Peer Average |
| Return On Equity | -0.54 | -0.31 |
| Return On Asset | -0.33 | -0.14 |
| Current Valuation | 359.6 M | 16.62 B |
| Shares Outstanding | 33.67 M | 571.82 M |
| Shares Owned By Insiders | 22.73 % | 10.09 % |
| Shares Owned By Institutions | 31.16 % | 39.21 % |
| Price To Book | 2.34 X | 9.51 X |
| EBITDA | (129.45 M) | 3.9 B |
| Net Income | (125.9 M) | 570.98 M |
| Cash And Equivalents | 219.15 M | 2.7 B |
| Cash Per Share | 9.69 X | 5.01 X |
| Total Debt | 553 K | 5.32 B |
| Current Ratio | 23.69 X | 2.16 X |
| Book Value Per Share | 5.19 X | 1.93 K |
| Cash Flow From Operations | (116.56 M) | 971.22 M |
| Earnings Per Share | (3.67) X | 3.12 X |
| Target Price | 65.0 | |
| Number Of Employees | 21 | 18.84 K |
| Beta | 0.89 | -0.15 |
| Market Capitalization | 483.48 M | 19.03 B |
| Total Asset | 333.49 M | 29.47 B |
| Net Asset | 333.49 M |
Ascelia Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ascelia . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Ascelia Pharma Buy or Sell Advice
When is the right time to buy or sell Ascelia Pharma AB? Buying financial instruments such as Ascelia Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ascelia Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Thematic Idea Now
Healthcare
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Healthcare theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Ascelia Stock Analysis
When running Ascelia Pharma's price analysis, check to measure Ascelia Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascelia Pharma is operating at the current time. Most of Ascelia Pharma's value examination focuses on studying past and present price action to predict the probability of Ascelia Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascelia Pharma's price. Additionally, you may evaluate how the addition of Ascelia Pharma to your portfolios can decrease your overall portfolio volatility.